Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population

    We compared the predictive ability of the International Prognostic Index (IPI), a frequently used prognostic model for peripheral T-cell lymphoma (PTCL), with that of a type-specific prognostic model, the Prog...

    Nobuhiko Nakamura, Nobuhiro Kanemura, Takuro Matsumoto in Scientific Reports (2023)

  2. Article

    Open Access

    Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study

    Long-acting injectable formulations for HIV infection have been approved and are now available in Japan. Although not currently recommended as first-line drugs in Japanese or overseas guidelines, use of such f...

    Masashi Ishihara, Shinichi Hikasa, Mariko Tsukiji in AIDS Research and Therapy (2023)

  3. Article

    Open Access

    Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma

    Extranodal involvement predicts poor outcomes of diffuse large B cell lymphoma (DLBCL), but the impact of the metabolic tumor burden (MTV) of extranodal sites using positron emission tomography has not been cl...

    Kana Oiwa, Kei Fujita, Shin Lee, Tetsuji Morishita in Annals of Hematology (2023)

  4. Article

    Open Access

    A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma

    This phase II clinical trial aimed to evaluate the efficacy and safety of the combination therapy of bendamustine, cytarabine, and rituximab (BRAC) in patients with relapsed or refractory follicular lymphoma (...

    Nobuhiko Nakamura, Senji Kasahara, Junichi Kitagawa in Experimental Hematology & Oncology (2022)

  5. Article

    Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin in Nature Medicine (2021)

  6. Article

    Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01253-5.

    Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin in Nature Medicine (2021)

  7. No Access

    Article

    Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Tumor protein p53 (TP53) is the most frequently mutated gene in cancer1,2. In patients with myelodysplastic syndromes (MDS), TP53 mutations are associated with high-risk disease3,4, rapid transformation to acute ...

    Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin in Nature Medicine (2020)

  8. No Access

    Article

    Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction

    Obinutuzumab is a novel glycoengineered, type-II anti-CD20 monoclonal antibody that was recently developed to treat follicular lymphoma (FL), the most prevalent subtype of indolent B-cell lymphoma. Several int...

    Takeshi Hara, Ryohei Suzuki, Akihisa Ohno in International Journal of Hematology (2020)

  9. Article

    Open Access

    Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling

    Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a diagnosis of exclusion, being the most common entity in mature T-cell neoplasms, and its molecular pathogenesis remains significantly unders...

    Yosaku Watatani, Yasuharu Sato, Hiroaki Miyoshi, Kana Sakamoto, Kenji Nishida in Leukemia (2019)

  10. No Access

    Article

    Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma

    Follicular lymphoma (FL) is an indolent lymphoma that often transforms into a high-grade lymphoma, mostly diffuse large B-cell lymphoma. A case of FL suggested to transform into plasmablastic lymphoma is prese...

    Toshiki Yamada, Takeshi Hara, Naoe Goto in International Journal of Hematology (2019)

  11. No Access

    Article

    Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia

    Skeletal muscle atrophy and loss of adipose tissue, referred to as sarcopenia and adipopenia, respectively, are often observed in cancer patients. We investigated the impact of sarcopenia and adipopenia on cli...

    Nobuhiko Nakamura, Soranobu Ninomiya, Takuro Matsumoto in Annals of Hematology (2019)

  12. Article

    Open Access

    Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study

    Dasatinib has shown promising anti-leukemic activity against chronic myeloid leukemia (CML). However, patients receiving dasatinib frequently require dose reductions and treatment interruptions (treatment alte...

    Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi in International Journal of Clinical Oncology (2018)

  13. Article

    Open Access

    Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy

    We previously reported that oral ingestion of polaprezinc, a zinc-L-carnosine, suspended in sodium alginate solution prevents oral mucositis in patients receiving radiotherapy or high-dose chemotherapy. In the...

    Hiroko Hayashi, Ryo Kobayashi, Akio Suzuki, Yuto Yamada in Medical Oncology (2016)

  14. No Access

    Article

    Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04)

    To evaluate the efficacy and feasibility of upfront high-dose chemotherapy (HDCT) and rituximab (R) followed by autologous peripheral blood stem cell transplantation (auto-PBSCT) in patients with newly diagnos...

    Tohru Murayama, Takahiro Fukuda, Hirokazu Okumura in International Journal of Hematology (2016)

  15. No Access

    Article

    Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions

    Toshiki Yamada, Yasuhito Nannya, Naoki Mita in International Journal of Hematology (2016)

  16. No Access

    Chapter

    Hematologic Diseases and Liver

    Liver involvement is often observed in several hematologic diseases, as shown by abnormal liver function tests, abnormalities in liver imaging studies, or clinical symptoms presenting with hepatic manifestatio...

    Nobuhiko Nakamura, Hisashi Tsurumi, Masahito Shimizu in The Liver in Systemic Diseases (2016)

  17. No Access

    Article

    Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma

    Sarcopenia reportedly predicts poor outcomes in elderly patients with diffuse large B-cell lymphoma (DLBCL). However, because previous studies only involved elderly patients, it is difficult to generalize thes...

    Nobuhiko Nakamura, Takeshi Hara, Yuhei Shibata, Takuro Matsumoto in Annals of Hematology (2015)

  18. No Access

    Article

    Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice

    Indoleamine 2,3-dioxygenase (IDO) catalyzes the rate-limiting step in the metabolism of tryptophan along the kynurenine pathway. In tumors, increased IDO activity inhibits proliferation and induces apoptosis o...

    Nobuhiko Nakamura, Takeshi Hara, Masahito Shimizu in International Journal of Hematology (2015)

  19. No Access

    Article

    Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures

    Mantle cell lymphoma (MCL) is a unique subtype of B-cell non-Hodgkin’s lymphoma characterized by chromosomal translocation t(11;14)(q13;q32), positive CD5, and nuclear cyclin D1 overexpression with unfavorable...

    Toshiki Yamada, Naoe Goto, Hisashi Tsurumi in Medical Molecular Morphology (2014)

  20. Article

    Open Access

    (—)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis

    Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to non-alcoholic steatohepatitis (NASH). NASH, which is accompanied by increased oxidative stress and inflammation in the liver, is associ...

    Takafumi Sumi, Yohei Shirakami, Masahito Shimizu, Takahiro Kochi in SpringerPlus (2013)

previous disabled Page of 3